Ocean Biomedical receives Nasdaq delisting notice for failing MVLS minimum

Ocean Biomedical, Inc.

Nasdaq notified Ocean Biomedical on Dec 5, 2024 that its MVLS was below $35M for 30 consecutive business days.
Company has 180 calendar days to regain compliance by closing MVLS at $35M+ for 10 consecutive business days.
Failure to cure within the compliance period may result in delisting of common stock and warrants from Nasdaq.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.